Tasigna cleared for use in children with rare leukemia by Selina McKee | Mar 23, 2018 | News | 0 The US Food and Drug Administration is allowing use of Novartis’ Tasigna to treat paediatric patients with a rare form of leukaemia. Read More
BMS, Novartis to test Mekinist/Opdivo combo by Selina McKee | Jun 6, 2017 | News | 0 Novartis and Bristol-Myers Squibb have signed a clinical research pact to investigate the safety, tolerability, and efficacy of combining their respective drugs Mekinist and Opdivo. Read More